ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Medical Oncology

Top Medical Oncology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MING ZHOU MD

Medical Oncology

3,786

$1.18M

325
293 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 21%

$312
Average prescription price

Avg: $382

KENNETH YAMAMOTO MD

Medical Oncology

3,718

$1.82M

329
293 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 21%

$490
Average prescription price

Avg: $382

RAYMUNDO ROMERO M.D.

Medical Oncology

3,677

$324K

371
305 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$88
Average prescription price

Avg: $382

SEUNG-YIL SONG M.D.

Medical Oncology

3,604

$750K

204
167 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$208
Average prescription price

Avg: $382

MANORAMA REDDY M.D.

Medical Oncology

3,102

$136K

145
103 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$44
Average prescription price

Avg: $382

THOMAS REYNOLDS MD

Medical Oncology

2,646

$230K

211
191 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$87
Average prescription price

Avg: $382

BYRON WILSON M.D.

Medical Oncology

2,518

$789K

278
251 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$313
Average prescription price

Avg: $382

MARK TURRILL M.D.

Medical Oncology

2,140

$619K

234
181 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$289
Average prescription price

Avg: $382

JOEL LESTER M.D.

Medical Oncology

1,894

$138K

111
105 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$73
Average prescription price

Avg: $382

ROBERT QUADRO M.D.

Medical Oncology

1,858

$542K

196
172 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

27%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 21%

$292
Average prescription price

Avg: $382

KAMBIZ AFRASIABI M.D.

Medical Oncology

1,853

$1.32M

81
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 9%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 21%

$712
Average prescription price

Avg: $382

ROBERT HAVARD MD

Medical Oncology

1,787

$318K

252
205 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 21%

$178
Average prescription price

Avg: $382

DAVID POTTER MD

Medical Oncology

1,669

$774K

208
152 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$464
Average prescription price

Avg: $382

MAY CHEN MD

Medical Oncology

1,655

$315K

205
177 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$190
Average prescription price

Avg: $382

NITIN ROHATGI M.D.

Medical Oncology

1,562

$612K

186
145 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 21%

$392
Average prescription price

Avg: $382

NATALIE MARSHALL MD

Medical Oncology

1,514

$430K

255
198 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$284
Average prescription price

Avg: $382

SHANE DORMADY M.D., PHD

Medical Oncology

1,501

$1.08M

194
169 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 21%

$717
Average prescription price

Avg: $382

MICHAEL FIGUEROA M.D

Medical Oncology

1,444

$1.28M

214
170 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$887
Average prescription price

Avg: $382

THOMAS CHEN M.D., PH.D.

Medical Oncology

1,196

$1.05M

186
165 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$881
Average prescription price

Avg: $382

ANTOINE SAYEGH M.D.

Medical Oncology

1,180

$644K

262
228 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$545
Average prescription price

Avg: $382

JOEL BERNSTEIN MD

Medical Oncology

1,171

$414K

151
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$354
Average prescription price

Avg: $382

DELPHINE ONG M.D.

Medical Oncology

1,142

$260K

155
134 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$228
Average prescription price

Avg: $382

GIRIBALA PATEL M.D.

Medical Oncology

1,137

$253K

174
160 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$222
Average prescription price

Avg: $382

DAVID HARRISON M.D.

Medical Oncology

1,124

$476K

129
102 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 21%

$423
Average prescription price

Avg: $382

PUSHPENDU BANERJEE M.D.

Medical Oncology

1,093

$631K

121
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$577
Average prescription price

Avg: $382

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank